ODDB.org: Open Drug Database

Fresenius Kabi (Schweiz) AG - Irinotecan Fresenius 100 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	61246	Sequence	02
Product name	Irinotecan Fresenius 100 mg/5 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01XX19	ATC-Description	Irinotecan
Introduction of Sequence	28.01.2011

Composition

irinotecani hydrochloridum trihydricum 100 mg, sorbitolum 225 mg, acidum lacticum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 5 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	100mg / 5ml

BAG: Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	100 mg

Inactive agents	Dose
Acidum Hydrochloridum ad Ph
Lactic Acid
Natrii Hydroxidum ad Ph
Sorbitol	225mg / 5ml

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
018		91.81	116.25	A	SL	No

2026	©ywesee GmbH